Tuesday, June 30, 2026 Live from SEC EDGAR

TOVXNYSE

Theriva Biologics, Inc.

Pharmaceutical Preparations · NV · CIK 894158

Developing oncolytic adenovirus therapeutics to treat cancer and related diseases

+ Watch View on EDGAR ↗

$14M

Market cap

$0.26

Last close

+4.1%

1D

+2.8%

5D

1.2M

Volume

Price · last 39 sessions-31.5%

May 4L $0.24 · H $0.38Jun 29

572

Total filings

Jun 29, 2026

Last filing

12/31

Fiscal year end

All 8-K · 348 10-Q · 71 DEF 14A · 31 424B5 · 29 10-K · 23 SC 13G · 20 DEFA14A · 14 8-K/A · 11

10-Q10-QMay 5, 2026 10-Q10-QNov 12, 2025 10-Q10-QAug 11, 2025 10-Q10-QMay 14, 2025 10-Q10-QNov 12, 2024 10-Q10-QAug 13, 2024 10-Q10-QMay 7, 2024 10-Q10-QNov 13, 2023 10-Q10-QAug 8, 2023 10-Q10-QMay 11, 2023 10-Q10-QNov 10, 2022 10-Q10-QAug 11, 2022 10-Q10-QMay 16, 2022 10-Q10-QNov 3, 2021 10-Q10-QAug 5, 2021 10-QFORM 10-QMay 5, 2021 10-QFORM 10-QNov 10, 2020 10-QFORM 10-QAug 6, 2020 10-QFORM 10-QMay 5, 2020 10-QFORM 10-QNov 4, 2019 10-Q10-QAug 8, 2019 10-Q10-QMay 8, 2019 10-QFORM 10-QNov 8, 2018 10-QFORM 10-QAug 8, 2018 10-QFORM 10-QMay 8, 2018 10-Q10-QNov 1, 2017 10-QFORM 10-QAug 3, 2017 10-QFORM 10-QMay 4, 2017 10-QFORM 10-QNov 1, 2016 10-Q10-QAug 3, 2016 10-QFORM 10-QMay 5, 2016 10-Q10-QNov 5, 2015 10-QFORM 10-QAug 10, 2015 10-QFORM 10-QMay 11, 2015 10-Q10-QNov 14, 2014 10-QFORM 10-QAug 14, 2014 10-Q10-QMay 15, 2014 10-Q10-QNov 14, 2013 10-QFORM 10-QAug 14, 2013 10-QFORM 10-QMay 15, 2013 10-QFORM 10-QNov 14, 2012 10-QFORM 10-QAug 14, 2012 10-Q10-QMay 15, 2012 10-QFORM 10-QNov 14, 2011 10-QFORM 10-QAug 15, 2011 10-Q10-QMay 16, 2011 10-Q10-QNov 15, 2010 10-Q10-QAug 16, 2010 10-QADEONA PHARMACEUTICALS, FORM 10-Q, 3/31/2010May 17, 2010 10-QFORM 10-Q, ADEONA PHARMACEUTICALSNov 16, 2009 10-QFORM 10QAug 14, 2009 10-QADEONA 10-Q, 3/31/2009May 15, 2009 10-QFORM 10-QNov 14, 2008 10-QFORM 10-QAug 14, 2008 10-QFORM 10-QMay 15, 2008 10-QSHEFFIELD PHARMACEUTICALS, INC. 10-Q/3-31-03May 13, 2003 10-QFORM 10-QNov 14, 2002 10-QFORM 10-Q FOR QUARTER ENDING JUNE 30, 2002Aug 14, 2002 10-QFORM 10-Q FOR QUARTER ENDING MARCH 31, 2002May 15, 2002 10-QFORM 10-Q FOR QUARTER ENDED SEPTEMBER 30, 2001Nov 14, 2001 10-QQUARTERLY REPORT FOR PERIOD ENDED JUNE 30, 2001Aug 14, 2001 10-QQUARTERLY REPORT DATED 3/31/01May 14, 2001 10-QQUARTERLY REPORT ENDED 9/30/00Nov 3, 2000 10-QQUARTERLY REPORT ENDED 6/30/00Aug 11, 2000 10-QFORM 10-QMay 15, 2000 10-QFORM 10-QNov 12, 1999 10-QFORM 10-QAug 13, 1999 10-QFORM 10-QMay 10, 1999 10-QFORM 10QNov 13, 1998 10-QFORM 10QAug 14, 1998 10-QFORM 10QMay 15, 1998

Similar companies

Comparable business profile · signals at a glance

GNLXGENELUX Corp$132.7M+1.1%WHWKWhitehawk Therapeutics, Inc.$205.7M+6.0%STROSUTRO BIOPHARMA, INC.$477.2M+9.3%PGENPRECIGEN, INC.$1.6B+1.0%VSTMVerastem, Inc.$360.3M+1.1%CADLCandel Therapeutics, Inc.$627.2M+5.8%